Noah A. Capurso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Noah A. Capurso has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Christopher Merrick
VA Connecticut Healthcare Syst, West Haven, CT USA
1 shared publicationCristina A. Madden
VA Connecticut Healthcare Syst, West Haven, CT USA
1 shared publication- David A. Ross
Google research
1 shared publication Ismene Petrakis
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
1 shared publication- Laila Knio
The University of North Carolina School of Medicine, Chapel Hill, USA
1 shared publication
Latest Publications
- 16 January 2025
- Published by Springer Nature in Current Addiction Reports
- Vol. 12 (1) , 1-7
Harm Reduction Strategies for Opioid Use Disorder
- 16 January 2025
- Published by Springer Nature in Current Addiction Reports
- Vol. 12 (1) , 1-7
Harm Reduction Strategies for Opioid Use Disorder
- 23 February 2021
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 82 (2)
A Case of Blunted Orally Disintegrating Olanzapine Effect Due to Coadministered Psyllium
Psyllium is often used to reduce constipation, but could it make a coadministered medication less effective? This report describes an unexpected interaction.
- 23 February 2021
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 82 (2)
A Case of Blunted Orally Disintegrating Olanzapine Effect Due to Coadministered Psyllium
Psyllium is often used to reduce constipation, but could it make a coadministered medication less effective? This report describes an unexpected interaction.
- 1 June 2017
- Published by Elsevier in Biological Psychiatry
- Vol. 81 (11) , e79-e81
As Hopes Have Flown Before: Toward the Rational Design of Treatments for Alcohol Use Disorder.
- 1 June 2017
- Published by Elsevier in Biological Psychiatry
- Vol. 81 (11) , e79-e81
As Hopes Have Flown Before: Toward the Rational Design of Treatments for Alcohol Use Disorder.
- 20 January 2017
- Published by Wiley in The American Journal on Addictions
- Vol. 26 (2) , 115-117
Naltrexone for the treatment of comorbid tobacco and pornography addiction
Co-occurring addictive disorders are common, however treatment strategies for this population have not been extensively studied. This is especially the case for behavioral addictions. We present a patient (N = 1) with tobacco use disorder and problematic pornography use treated with naltrexone. Naltrexone treatment resulted in a decrease in pornography viewing and cigarette smoking, however had the adverse effect of anhedonia. A lower dose modestly impacted pornography viewing but not smoking. Relevant literature regarding co-occurring addictions as well as use of naltrexone is reviewed. This report represents the first case of tobacco and pornography co-addiction in the literature and supports the assertion that treatment of one addictive disorder can benefit another in the dually addicted patient. The efficacy of naltrexone for smoking is notable as previous studies of naltrexone in smoking have been disappointing. This case suggests future treatment strategies for comorbid addictions. (Am J Addict 2017;26:115–117)
- 20 January 2017
- Published by Wiley in The American Journal on Addictions
- Vol. 26 (2) , 115-117
Naltrexone for the treatment of comorbid tobacco and pornography addiction
Co-occurring addictive disorders are common, however treatment strategies for this population have not been extensively studied. This is especially the case for behavioral addictions. We present a patient (N = 1) with tobacco use disorder and problematic pornography use treated with naltrexone. Naltrexone treatment resulted in a decrease in pornography viewing and cigarette smoking, however had the adverse effect of anhedonia. A lower dose modestly impacted pornography viewing but not smoking. Relevant literature regarding co-occurring addictions as well as use of naltrexone is reviewed. This report represents the first case of tobacco and pornography co-addiction in the literature and supports the assertion that treatment of one addictive disorder can benefit another in the dually addicted patient. The efficacy of naltrexone for smoking is notable as previous studies of naltrexone in smoking have been disappointing. This case suggests future treatment strategies for comorbid addictions. (Am J Addict 2017;26:115–117)
- 15 March 2016
- Published by Wiley in The American Journal on Addictions
- Vol. 25 (3) , 188-190
Dyslipidemia associated with heavy alcohol use
Background and Objectives: Alcohol has many effects on lipid metabolism and has been associated with elevated triglycerides. The purpose of this paper is to report a case of globally dysregulated lipids secondary to alcohol use and to describe the natural history of this phenomenon after drinking cessation.Methods: We present a case of an otherwise healthy patient (N = 1) who was admitted to our facility for alcohol detoxification and found to have extreme lipid dysregulation. He was treated with benzodiazepines for alcohol withdrawal but no hypolipidemic agents were given.Results: Lipid indices self‐corrected and were found to be normal following just several weeks of sobriety in the absence of treatment with any hypolipidemic agents.Discussion: The literature regarding the effects of alcohol on lipid metabolism is briefly reviewed followed by a discussion of how these findings might apply to this patient in particular as well as implications for broader clinical practice.Conclusion and Scientific Significance: Alcohol has the ability to dysregulate several lipid indices in addition to elevating triglycerides. The rapid resolution of dyslipidemia suggests that additional treatment may not be necessary for patients who are able to abstain from alcohol but that hypolipidemic agents may be indicated for those patients who continue to drink. Additionally, clinicians should consider checking lipid panels in patients who present with alcohol intoxication and are found to have other laboratory abnormalites or those who have risk factors for hyperlipidemia. (Am J Addict 2016;25:188–190)
- 15 March 2016
- Published by Wiley in The American Journal on Addictions
- Vol. 25 (3) , 188-190
Dyslipidemia associated with heavy alcohol use
Background and Objectives: Alcohol has many effects on lipid metabolism and has been associated with elevated triglycerides. The purpose of this paper is to report a case of globally dysregulated lipids secondary to alcohol use and to describe the natural history of this phenomenon after drinking cessation.Methods: We present a case of an otherwise healthy patient (N = 1) who was admitted to our facility for alcohol detoxification and found to have extreme lipid dysregulation. He was treated with benzodiazepines for alcohol withdrawal but no hypolipidemic agents were given.Results: Lipid indices self‐corrected and were found to be normal following just several weeks of sobriety in the absence of treatment with any hypolipidemic agents.Discussion: The literature regarding the effects of alcohol on lipid metabolism is briefly reviewed followed by a discussion of how these findings might apply to this patient in particular as well as implications for broader clinical practice.Conclusion and Scientific Significance: Alcohol has the ability to dysregulate several lipid indices in addition to elevating triglycerides. The rapid resolution of dyslipidemia suggests that additional treatment may not be necessary for patients who are able to abstain from alcohol but that hypolipidemic agents may be indicated for those patients who continue to drink. Additionally, clinicians should consider checking lipid panels in patients who present with alcohol intoxication and are found to have other laboratory abnormalites or those who have risk factors for hyperlipidemia. (Am J Addict 2016;25:188–190)